What sector does Tekla Life Sciences Investors (HQL) operate in?
Tekla Life Sciences Investors belongs to the Financials sector and operates in the Asset Management industry.
What is Tekla Life Sciences Investors (HQL) current stock price?
As of the latest data, Tekla Life Sciences Investors stock price is $17.16, with a previous close of $17.22. Tekla Life Sciences Investors lost -$0.06 in the last trading session, representing a -0.35% loss.
What is Tekla Life Sciences Investors (HQL) current market capitalization?
Tekla Life Sciences Investors market cap is approximately 507.91 million.
What is Tekla Life Sciences Investors (HQL) Earnings Per Share (EPS)?
The trailing EPS is $2.79.
What is Tekla Life Sciences Investors (HQL) Price-to-Earnings (P/E) ratio?
Tekla Life Sciences Investors current P/E ratio is 6.15.
Does Tekla Life Sciences Investors (HQL) pay dividends?
Yes. Tekla Life Sciences Investors pays quarterly dividends with an annualized yield of 13.05% and an estimated annual payout of $2.24 per share.
When is the next ex-dividend date for Tekla Life Sciences Investors (HQL)?
The next ex-dividend date is scheduled for May 22, 2026.
What is Tekla Life Sciences Investors (HQL) beta (volatility) score?
Tekla Life Sciences Investors has a beta of 0.739, indicating lower volatility than the overall market.